Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01998009 · ClinicalTrials.gov registry record · NA

Study of In-home Tests for Colorectal Cancer

A NA study, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
NA
Development phase
1,382
Enrollment target

NCT01998009 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,382 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01998009, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
NA
Development phase
1,382 participants
Enrollment target

Study Summary

The objective of this study is to compare the performance characteristics or accuracy of different in-home screening tests for colorectal cancer (fecal occult blood tests), among patients without symptoms of colorectal cancer. Patients who meet study eligibility criteria and agree to participate in the study are asked to perform one guaiac and two immunochemical fecal occult blood tests at home prior to their colonoscopy. After the patient has completed and sent in the test kits, the patient then undergoes their previously scheduled colonoscopy. Accuracy and performance characteristics for each type of fecal occult blood test, including sensitivity, specificity, test positivity rate and positive predictive value for advanced colorectal neoplasia (advanced colorectal polyps) or colorectal cancer, will be estimated by comparing the fecal occult blood test results with the results of the colonoscopy.

Interventions

  • OTHER fecal occult blood tests

Trial Details

FieldValue
Enrollment Target 1,382 participants
Start Date 2011-05
Est. Completion 2014-09
Phase NA

What the Registry Record Tells You About NCT01998009

The ClinicalTrials.gov registry entry for NCT01998009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,382 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which fecal occult blood tests is the first listed.

NCT01998009 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01998009 about?

NCT01998009 is a clinical study titled "Study of In-home Tests for Colorectal Cancer". The objective of this study is to compare the performance characteristics or accuracy of different in-home screening tests for colorectal cancer (fecal occult blood tests), among patients without symptoms of colorectal cancer. Patients who meet study eligibility criteria and agree to participate in ...

What is the current status of trial NCT01998009?

This trial is currently completed. It is a NA study. The enrollment target is 1,382 participants. The study started on 2011-05. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01998009?

The interventions under investigation include: fecal occult blood tests (OTHER).

Who is sponsoring clinical trial NCT01998009?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.